Centre National de la Recherche Scientifique Université de Strasbourg Institut des Neurosciences Cellulaires et Intégratives UPR3212 Strasbourg France

Department of Neurology University Hospital Olomouc Olomouc Czech Republic

Department of Neurosurgery Svet Zdravia Hospital Michalovce Michalovce Slovak Republic

Laboratory of Experimental Medicine Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc Czech Republic

Neurosurgery. 2022 Aug 1;91(2):360-369. doi: 10.1227/neu.0000000000002026. PubMed

Zobrazit více v PubMed

Wang L. Letter: Transcriptomic profiling revealed Lnc-GOLGA6A-1 as a novel prognostic biomarker of meningioma recurrence. Neurosurgery. 2022;91(6):e175.

Slavik H, Balik V, Kokas FZ, et al. Transcriptomic profiling revealed Lnc-GOLGA6A-1 as a novel prognostic biomarker of meningioma recurrence. Neurosurgery. 2022;91(2):360-369.

Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122(1):4-23.

Balik V, Kourilova P, Sulla I, et al. Recurrence of surgically treated parasagittal meningiomas: a meta-analysis of risk factors. Acta Neurochir (Wien). 2020;162(9):2165-2176.

Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22.

Brastianos PK, Galanis E, Butowski N, et al. Advances in multidisciplinary therapy for meningiomas. Neuro-Oncology. 2019;21(supplement_1):i18-i31.

Lemée JM, Corniola MV, Da Broi M, et al. Extent of resection in meningioma: predictive factors and clinical implications. Sci Rep. 2019;9(1):5944.

Slot KM, Verbaan D, Bosscher L, Sanchez E, Vandertop WP, Peerdeman SM. Agreement between extent of meningioma resection based on surgical simpson grade and based on postoperative magnetic resonance imaging findings. World Neurosurg. 2018;111:e856-e862.

Chotai S, Schwartz TH. The Simpson grading: is it still valid? Cancers. 2022;14(8):2007.

Slavik H, Balik V, Vrbkova J, et al. Identification of meningioma patients at high risk of tumor recurrence using microRNA profiling. Neurosurgery. 2020;87(5):1055-1063.

Katz LM, Hielscher T, Liechty B, et al. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 2018;135(6):955-963.

Nassiri F, Liu J, Patil V, et al. A clinically applicable integrative molecular classification of meningiomas. Nature. 2021;597(7874):119-125.